Outpatient CD19-directed CAR T-cell therapy is feasible in patients of all ages.
Ly A, Sanber K, Tsai HL, Ondo A, Mooney K, Shedeck A, Baker J, Imus PH, Wagner-Johnston N, Jain T.
Ly A, et al. Among authors: mooney k.
Br J Haematol. 2023 Nov;203(4):688-692. doi: 10.1111/bjh.19090. Epub 2023 Aug 29.
Br J Haematol. 2023.
PMID: 37642134
No abstract available.